The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in parkinson's disease
- 1 January 1993
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 8 (S1) , S8-S13
- https://doi.org/10.1002/mds.870080504
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The molecular pharmacology of L-deprenylEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Novel substrates and products of amine oxidase-catalysed reactionsBiochemical Society Transactions, 1991
- Monoamine Oxidase Activity and Monoamine Metabolism in Brains of Parkinsonian Patients Treated with l‐DeprenylJournal of Neurochemistry, 1986
- The deamination of dopamine by human brain monoamine oxidaseNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1983
- (-)-Deprenyl Leads to Prolongation of L-Dopa Efficacy in Parkinson s DiseasePublished by S. Karger AG ,1982
- Metabolism of acetylpolyamines by monoamine oxidase, diamine oxidase and polyamine oxidaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1981
- EVIDENCE FOR DOPAMINE DEAMINATION BY BOTH TYPE A AND TYPE B MONOAMINE OXIDASE IN RAT BRAIN in vivo AND FOR THE DEGREE OF INHIBITION OF ENZYME NECESSARY FOR INCREASED FUNCTIONAL ACTIVITY OF DOPAMINE AND 5‐HYDROXYTRYPTAMINEBritish Journal of Pharmacology, 1977
- Dopamine is a monoamine oxidase B substrate in manNature, 1977
- Putrescine catabolism in mammalian brainBiochemical Journal, 1974
- Acetyl-CoA:1,4-diaminobutane N-acetyltransferase occurence in vertebrate organs and subcellular localizationBiochimica et Biophysica Acta (BBA) - General Subjects, 1974